About (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide
(2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide (PubChem CID 10290012) has the molecular formula C25H29ClF2N4O7S
and a molecular weight of 603.04 g/mol. Its IUPAC name is (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide.
Molecular Properties
| Compound Name | (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide |
| PubChem CID | 10290012 |
| Molecular Formula | C25H29ClF2N4O7S |
| Molecular Weight | 603.04 g/mol |
| Exact Mass | 602.14 |
| IUPAC Name | (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide |
| SMILES | O=C(NO)[C@H](CC1CCN(C(=O)N2CCOCC2)CC1)NS(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1 |
| InChI | InChI=1S/C25H29ClF2N4O7S/c26-17-1-3-18(4-2-17)39-23-20(27)14-19(15-21(23)28)40(36,37)30-22(24(33)29-35)13-16-5-7-31(8-6-16)25(34)32-9-11-38-12-10-32/h1-4,14-16,22,30,35H,5-13H2,(H,29,33)/t22-/m0/s1 |
| InChIKey | RZTKJAPRQOWGTE-QFIPXVFZSA-N |
| XLogP | 3.12 |
| TPSA | 137.51 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 603.04 |
| LogP ≤ 5 | 3.12 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide?
The IUPAC name of (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide (CID 10290012) is (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide.
What is the SMILES notation for (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide?
The canonical SMILES for (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide is O=C(NO)[C@H](CC1CCN(C(=O)N2CCOCC2)CC1)NS(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1.
What is the InChIKey of (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide?
The InChIKey is RZTKJAPRQOWGTE-QFIPXVFZSA-N. The full InChI is InChI=1S/C25H29ClF2N4O7S/c26-17-1-3-18(4-2-17)39-23-20(27)14-19(15-21(23)28)40(36,37)30-22(24(33)29-35)13-16-5-7-31(8-6-16)25(34)32-9-11-38-12-10-32/h1-4,14-16,22,30,35H,5-13H2,(H,29,33)/t22-/m0/s1.
What are the key properties of (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide?
(2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide has a molecular weight of 603.04 g/mol, XLogP of 3.12, 8 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[[4-(4-chlorophenoxy)-3,5-difluorophenyl]sulfonylamino]-N-hydroxy-3-[1-(morpholine-4-carbonyl)piperidin-4-yl]propanamide is sourced from PubChem (CID 10290012), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).